GlassScriptPhysician profile
Kintur Sanghvi
NPI 1770627200
$139,050.03
in general payments reported to CMS, 2019-2025
29 companies · $53K in 2025
The $53K reported for 2025 was more than what 97% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $12K · 2021: $19K · 2022: $608 · 2023: $2,503 · 2024: $27K · 2025: $53K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $34K · Consulting Fee: $33K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,281 · Food and Beverage: $6,400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $33,534.35 |
| Consulting Fee | $33,120.83 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,281.25 |
| Food and Beverage | $6,399.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $78,151.56 | 2021-2025 | Symplicity G3, Corevalve Evolut R, Onyx Frontier |
| Cordis Corporation | $25,806.71 | 2020-2021 | |
| Cardinal Health 200 LLC | $19,343.72 | 2019-2021 | |
| Medtronic Vascular, INC. | $5,653.80 | 2019-2020 | |
| Cordis US Corp. | $4,281.88 | 2021-2023 | Railway |
| Edwards Lifesciences Corporation | $1,784.56 | 2019-2025 | Evoque, Pascal |
| Penumbra, INC. | $574.26 | 2024-2025 | Indigo System, Penumbra System |
| Boston Scientific Corporation | $564.86 | 2019-2025 | Avvigo Guidance System, Eluvia |
| Abiomed | $546.59 | 2022-2025 | Impella |
| Nevro Corp. | $502.70 | 2021-2022 | |
| Siemens Medical Solutions USA, INC. | $359.77 | 2024 | Artis Icono Floor, Artis Icono Biplane |
| Cardiovascular Systems INC. | $321.88 | 2019-2021 | |
| Inari Medical, INC. | $314.33 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| W. L. Gore & Associates, INC. | $214.27 | 2021-2025 | Gore Cardioform Septal Occluder |
| Shockwave Medical, INC | $193.90 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $161.81 | 2022-2023 | Verquvo |
| Angiodynamics, INC. | $40.85 | 2021-2023 | Auryon Laser System 100-120 Vac |
| Recor Medical INC | $36.75 | 2025 | Paradise Ultrasound Renal Denervation System |
| Amgen INC. | $30.34 | 2024-2025 | |
| Abbott Laboratories | $22.76 | 2024 | Navitor |
| Chiesi USA, INC. | $21.65 | 2024 | Kengreal |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.19 | 2021 | |
| Kestra Medical Technology Services, INC. | $17.77 | 2023 | Assure Wcd |
| Astrazeneca Pharmaceuticals LP | $15.99 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $15.70 | 2025 | Eliquis |
| Irhythm Technologies, INC. | $15.54 | 2023 | Zio Xt Patch |
| Alnylam Pharmaceuticals INC. | $13.39 | 2023 | Onpattro |
| Bardy Diagnostics, INC. | $12.00 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $11.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kintur Sanghvi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.